JN Journal of Neurophysiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Neurophysiol 89: 128-134, 2003; doi:10.1152/jn.00700.2002
0022-3077/03 $5.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (23)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ramadan, E.
Right arrow Articles by Vicini, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ramadan, E.
Right arrow Articles by Vicini, S.

J Neurophysiol (January 1, 2003). 10.1152/jn.00700.2002
Submitted on Submitted 19 August 2002; accepted in final form 24 September 2002

GABAA Receptor beta 3 Subunit Deletion Decreases alpha 2/3 Subunits and IPSC Duration

Epolia Ramadan,1 Zhanyan Fu,2 Gabriele Losi,2 Gregg E. Homanics,3 Joseph H. Neale,1 and Stefano Vicini2

 1Department of Biology,  2Department of Physiology and Biophysics, Georgetown University School of Medicine, Washington, DC 20057; and  3Departments of Anesthesiology and Pharmacology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15261


    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

Ramadan, Epolia, Zhanyan Fu, Gabriele Losi, Gregg E. Homanics, Joseph H. Neale, and Stefano Vicini. GABAA Receptor beta 3 Subunit Deletion Decreases alpha 2/3 Subunits and IPSC Duration. J. Neurophysiol. 89: 128-134, 2003. Deletion of the beta 3 subunit of the GABAA receptor produces severe behavioral deficits and epilepsy. GABAA receptor-mediated miniature inhibitory postsynaptic currents (mIPSCs) in cortical neurons in cultures from beta 3 -/- mice were significantly faster than those in beta 3 +/+ mice and were more prolonged by zolpidem. Surface staining revealed that the number of beta 2/3, alpha 2, and alpha 3 (but not of alpha 1) subunit-expressing neurons and the intensity of subunit clusters were significantly reduced in beta 3 -/- mice. Transfection of beta 3 -/- neurons with beta 3 cDNA restored beta 2/3, alpha 2, and alpha 3 subunits immunostaining and slowed mIPSCs decay. We show that the deletion of the beta 3 subunit causes the loss of a subset of GABAA receptors with alpha 2 and alpha 3 subunits while leaving a receptor population containing predominantly alpha 1 subunit with fast spontaneous IPSC decay and increased zolpidem sensitivity.


    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

GABAA receptor channels are responsible for inhibitory synaptic transmission in the majority of neurons in the CNS and have considerable heterogeneity of constituting subunits (Olsen and MacDonald 2002). The pivotal role that GABAA receptor subunits play in brain functions has been demonstrated by the large array of behavioral effects caused by deletions of individual constituting subunits (Mohler 2002). The deletion of the beta 3 subunit produces developmental and neurological impairments including premature death, epileptic convulsion, and Angelman syndrome-like features (Homanics et al. 1997). In contrast, deletion of the beta 2 subunit has little behavioral consequence in spite of the dramatic decrease (~50%) in GABAA receptor expression in these mice (Sur et al. 2001). How can one reconciliate these contrasting results? Compensatory alteration of subunit expression, assembly, or targeting may underlie some of these differences. However, no compensatory upregulation of other beta  subunit isoforms has been observed in beta 3 -/- mice (Homanics et al. 1997). An intriguing alternative possibility is that particular subunits need to be associated to be expressed at the neuronal membrane surface. Indeed a pivotal role for beta  subunit in surface expression and localization has been demonstrated (Connolly et al. 1996, Connor et al. 1998).

At inhibitory synapses, the duration of GABA action is reflected in the time course of the inhibitory postsynaptic currents (IPSCs). The IPSCs time course determines synaptic strength and is the target of the action of several commonly prescribed tranquilizer, sedative, and antiepileptic drugs (MacDonald and Olsen 1994). Ultrarapid agonist applications studies with recombinant receptors revealed that the presence of specific alpha  subunits determines the time course of GABA responses. Specifically, receptor isoforms containing the alpha 1 subunit have a faster time course than those with alpha 2 or alpha 3 subunits. (Gingrich et al. 1995; Lavoie et al. 1997; McClellan and Twyman 1999; Verdoon 1994). Studies in neurons of transgenic mice lacking the alpha 1 subunit (Vicini et al. 2001) as well as in neurons over expressing this subunit (Okada et al. 2000) indicate that the presence of the alpha 1 subunit can indeed shorten IPSCs duration. The presence of the alpha 1 subunit can be confirmed by prolongation of sIPSCs with zolpidem, a selective imidazopyridine for benzodiazepine type 1 receptors that contain this subunit (MacDonald and Olsen 1994, Pritchett et al. 1989).

Electrophysiological studies from neurons derived from beta 3 -/- mice have demonstrated a dramatic reduction of maximal GABA evoked whole cell currents in acutely dissociated DRG neurons and to a lesser extent in cultured hippocampal neurons (Homanics et al. 1997, Krasowski et al. 1998). In addition, smaller and faster sIPSCs were recorded both in neurons of the reticular thalamic nucleus (Huntsman et al. 1999) and granule neurons in the olfactory bulb (Nusser et al. 2001) in slices from beta 3 -/- mice.

We investigated the properties of sIPSCs and the action of zolpidem on their duration in cultured cortical neurons from beta 3 -/- mice. Our electrophysiological results, supported by immunocytochemical studies, suggest that the observed shortening of sIPSC duration in beta 3 -/- mice is the result of an altered expression of alpha  subunits.


    METHODS
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

All studies were conducted with an approved protocol from Georgetown University and University of Pittsburgh Animal Care and Use Committees in compliance with the National Institutes of Health guidelines for the care and use of experimental animals.

Mutant mice production

beta 3-subunit-deficient mice were produced at the University of Pittsburgh and Georgetown University as described (Homanics et al. 1997). Matings between beta 3 ± mice (>F10 generation; mixed C57BL/6J × Strain 129Sv/SvJ genetic background) were set up in the late afternoon and checked for vaginal plugs the next morning. The day of plug detection was designated embryonic day 0.5 (E0.5).

Embryos (E16.5-17.5) from heterozygous intercrosses were genotyped by PCR amplification of genomic DNA extracted from liver using the hot sodium hydroxide and Tris (HotSHOT) protocol (32) (Truett et al. 2000). Briefly, embryonic liver samples were lysed with 75 µl of an alkaline lysis reagent (25 mM NaOH, 0.2 mM disodium EDTA; pH 12) at 95°C for 40 min. Subsequently, samples were cooled to 4°C for 30 min, and 75 µl of a neutralizing reagent (40 mM Tris-HCl; pH 5) was added. One to 5 µl of the final preparation was used per 12 µl PCR reaction. The amplification mixture contained genomic DNA, 2.0 mM MgCl2, 0.2 mM dNTP, PCR buffer, 0.02 U/µl Ampli. Taq Polymerase (Perkin Elmer No. 808-0161) 0.8 µM oIMR 372 primer (primer for beta 3 exon 3: 5'-GCATCGACATGGTTTCTGAAGTC-3'), 0.8 µM oIMR 374 primer (primer for NEO cassette: 5'-CAGAAAGCGAAGGAACAAAGCTG), and 1 µM oIMR 373 primer (common beta 3 reverse primer: 5'-GGGCTACTGATCTCCTCTTTCCAC-3'). The PCR conditions were according to the Jackson Laboratory's genotyping protocol. The assay used a "touchdown cycling" to reduce nonspecific amplification products. For the first 12 cycles, the annealing temperature (starting at 64°C) was reduced by 0.5°C/cycle. For the remaining 25 cycles, the annealing temperature remained at 58°C. PCR amplification from beta 3 +/+ mice produced a 690-bp product, beta 3 ± produced 690- and 490-bp products, and beta 3 -/- produced a 490-bp product and had a pink eye phenotype.

Primary cortical neuronal cultures.

Cortical neuronal cultures were prepared from individual embryonic mice (E17-18) from both genotypes. Briefly, the cortex were chopped after careful dissection and digested in 0.28% trypsin (Sigma, St Louis, MO) for 15 min at 37°C with gentle shaking. Dissociated cells were inoculated at a density of 0.75 × 106 in a 35-mm dish on poly-L-lysine-coated coverslips in basal Eagle medium (BME, Invitrogen, Carlsbad, CA) containing 10% FBS, 2 mM glutamine, 100 µg/ml gentamicin (all from Invitrogen), and 25 mM KCl, and maintained at 37°C in 5% CO2. After 24 h in vitro, the medium was replaced with 50:50 mixture of BME and Neurobasal medium containing 2% B27 supplement, 1% antibiotic, and 0.25% glutamine (Invitrogen). At 5 days in vitro (DIV5), cytosine arabinofuranoside was added at final concentration of 10 µM. Thereafter, half of the medium was replaced twice a week with Neurobasal medium containing 2% B27 supplement, 1% antibiotic, and 0.25% glutamine.

CORTICAL NEURON TRANSFECTION. We transfected primary cultures of beta 3 -/- mouse cortical neurons with 1 µg of GABAA receptor rat beta 3 subunit (a gift of Dr. Peter H. Seeburg, University of Heidelberg, Germany) subcloned into the expression vector pCDM8 (Invitrogen) and the enhanced green fluorescent protein (EGFP) plasmid (0.3 µg, Clontech, Palo Alto, CA, No. 6077-1) to allow visualization of successfully transfected cells. A modification of the calcium phosphate precipitation technique (Chen and Okayama 1987) was used. Briefly, cultured neurons at DIV5 on glass coverslips were transferred to a well in a four-well plate with 500 µl transfection medium, a MEM medium (Invitrogen) with pH adjusted to 7.85 by 5 M NaOH. Then 30 µl of the DNA/Ca2+ mixture was added and incubated for 30 min at room temperature. After two washes with transfection medium, the original culture medium was returned and neurons were maintained at 37°C in 5% CO2 for several days.

IMMUNOCYTOCHEMISTRY. Live cultured neurons were incubated in anti-alpha 1 (4 µg/ml, Upstate, Waltham, MA), anti-alpha 2 (1:3000), anti-alpha 3 (1:3000), anti alpha 5 (1:2000), kind gifts from Dr. Jean Marc Fritschy (University of Zurich, Switzerland), and anti beta 2/3 (4 µg/ml, Upstate) antibodies for 90 min at room temperature. Cells were washed and fixed in 4% paraformaldehyde, 4% sucrose in PBS for 15 min at room temperature. Cells were then incubated in 10% goat serum for 30 min to block nonspecific staining. After washing with PBS several times, cells were incubated with indocarbocyanine (Cy3) conjugated secondary antibodies (1:500, Jackson ImmunoResearch Laboratories, West Grove, PA) for 1 h at room temperature. Nikon band-pass filter cubes were used for Cy3 or EGFP fluorescence. Neurons were imaged on a Nikon EN600 microscope equipped with a ×20 Ph2 0.5 N.A. and a ×60, 1.0 N.A. objective. Digital images were acquired with a Hamamatsu Orca-100, 12-bit (4,096 gray-scale intensity level) cooled CCD digital camera, 1,392 × 1,040 pixel array. The expression of GABAA receptor subunits was investigated in DIV15 cortical neurons. Fluorescence intensity was measured from region of interest transferred with MetaMorph image analysis software (Universal Imaging, Downingtown, PA) from phase contrast microphotographs taken with a ×20 objective to mark the outline of individual neurons and to avoid bias. Cells were considered positive when staining intensity was greater that twice the background. To count dendritic clusters, a single level of focus was maintained throughout each recording. Recording at a single focal plane was usually sufficient to capture GABA receptor clusters throughout the full thickness of small distal dendrites but not of proximal dendrites or cell body. Thus for our measurements, we estimated the number of clusters only in distal dendrites. To quantitate changes in clustering, we measured the average pixel intensity of all clusters along a dendritic segment. Measurement of average fluorescence intensity was performed using MetaMorph. Several neurons from two to three coverslips per culture were randomly selected on the basis of healthy morphology and scored to determine the percentage of clusters in segments of dendrites of >= 50 µm length. CCD images were background subtracted, and to define clusters, a single threshold was chosen manually so that clusters corresponded to puncta of at least twofold greater intensity than the diffuse fluorescence on the dendritic shaft. A minimum size of 3 pixels was considered to define a cluster, pixel size at ×60 magnification was 0.109 µm.

ELECTROPHYSIOLOGY. Cortical neurons were voltage-clamped at room temperature. The recording chamber was continuously perfused at 5 ml/min with an extracellular medium composed of (in mM) 145 NaCl, 5 KCl, 1mM MgCl2, 2 CaCl2, 5 glucose, and 5 HEPES at pH 7.4 with NaOH. Osmolarity was adjusted to 325 mosM with sucrose. Electrodes were pulled in two stages on a vertical pipette puller from borosilicate glass capillaries (Wiretrol II, Drummond). Typical pipette resistance was 5-7 MOmega . Intracellular (patch pipette) solutions contained (in mM) 145 CsCl, 5 MgATP, 10 bis-(o-aminophenoxy)-N,N,N',N'-tetraacetic acid (BAPTA), 0.2 NaGTP, and 10 HEPES at pH 7.2 with CsOH. Whole cell recordings were performed with a patch-clamp amplifier (Axopatch 200, Axon Instrument, CA) after capacitance and series resistance compensation. Series resistance was typically <15 MOmega and was checked for constancy throughout the experiments. GABA was applied directly by gravity-fed Y-tubing delivery system (Murase et al. 1989) placed within 100 µm of the recorded cell. GABA application had fast onset (<20ms) and achieved a completely local perfusion of the recorded cell. Repeated applications were followed each time by a recovery period of >= 2 min. The peak amplitude of responses to individual GABA concentration was measured and normalized to the maximal GABA current. Dose-response curves were fitted with the logistic equation
% <IT>I</IT><SUB><IT>max</IT></SUB><IT>=100/</IT><IT>I</IT><SUB><IT>max</IT></SUB>{<IT>1+</IT>(<IT>EC<SUB>50</SUB>/</IT>[<IT>GABA</IT>]<SUP><IT>n</IT><SUB><IT>h</IT></SUB></SUP>)}
where Imax is the maximal Cl- current, elicited by GABA, EC50 is the GABA concentration eliciting the half-maximal response, and nh is the Hill coefficient. Drugs were also coapplied with GABA after a short period of preperfusion before coapplication with GABA to observe maximal potentiation. Zolpidem (Sigma) and Loreclezole (a gift from Janssen Research Foundation, Beerse Belgium) were dissolved in dimethylsulfoxide (DMSO, <0.001% final concentration, Sigma) and diluted in the extracellular medium. They were superfused through a parallel input to the perfusion chamber until effective replacement of the solution was obtained for synaptic current recordings. Miniature IPSCs (mIPSCs), a subset of spontaneous IPSCs (sIPSCs), were recorded in the presence of tetrodotoxin (TTX 1 µM, Sigma). Currents were filtered at 2 kHz with an 8-pole low-pass Bessel filter (Frequency Devices, Haverhill, MA), digitized using a PC-compatible microcomputer equipped with a Digidata 1200 data-acquisition board (Axon Instruments) and Pclamp8 (Axon Instrument) software. Off-line data analysis, curve fitting, and figure preparation were performed with Origin (MicroCal Software, Northampton, MA), PClamp 8.0 (Axon Instrument) and Mini Analysis (Synaptosoft, www.synaptosoft.com, Decatur, GA) softwares. For each cell, mIPSC were averaged from 100 events aligned on the point of steepest rise. Peak amplitudes were measured at the absolute maximum of the currents, taking into account the noise of the baseline and noise around the peak. Rise times were measured as the time elapsed from 10 to 90% of the peak amplitude of the response. Curve fitting was performed using simplex algorithm least-squares exponential fitting routines with double exponential equations of the form I(t) = Ife (-t/tau f) + Ise (-t/tau s) where If and Is are the amplitudes of the fast and slow decay components, and tau f and tau s are their respective decay time constants. To compare decay times between different experimental conditions, we used a weighted mean decay time constant tau w = [If/(If + Is)]tau f + [Is/(If + Is)]tau s. Drug effects were assessed based on averages of 100 events in each neuron by statistical comparisons. Unless otherwise indicated, data are expressed as mean ± SE; P values represent the results of independent t-test with Bonferroni corrections, or Newmann-Kuel test with prior ANOVA for repeated measures as appropriate.


    RESULTS
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

GABA responses in beta 3 -/- neurons

We investigated GABA activated currents in cortical neurons at day 7 in vitro (DIV7) from beta 3 +/+ and beta 3 -/- mice. To allow a comparison between neurons with different size and dendritic arborization, we used excised nucleated patches (Sather et al. 1992) that have a considerable amount of membrane and at the same time allow better quality voltage clamping and more reliable drug application. The application of increasing GABA concentrations elicited inward currents in these patches when symmetrical Cl- concentrations were present in the intracellular recording pipette solution and in the extracellular bath solution (Fig. 1, A and B). Analysis of the dose response (Fig. 1C) yielded slightly different EC50, but current density values were significantly smaller for patches from beta 3 -/- neurons (Fig. 1D).



View larger version (21K):
[in this window]
[in a new window]
 
Fig. 1. Dose-response of GABA-elicited Cl- currents in cortical neurons from beta 3 -/- mice. Representative Cl- currents (voltage-clamped at -60 mV holding potential) were elicited in nucleated patches from neurons at day 7 in vitro (DIV7) derived from beta 3 +/+ (A) and beta 3 -/- (B) mice. GABA applications at increasing concentrations were performed for the duration indicated by the bars. The average of GABA dose-response curves normalized to the maximal current in individual neurons (C) and the current density, maximal current normalized by the cell capacitance (D), derived from neurons in >= 3 beta 3 +/+ and 3 beta 3 -/- mice. EC50 values were 7.4 ± 1.1 µM (+/+) and 15.8 ± 1.2 µM (-/-). Number of cells is indicated in parenthesis. *P < 0.005.

To verify the expression of distinct functional GABAA receptors between beta 3 +/+ and beta 3 -/- mice, we compared the allosteric modulation of GABAA receptors by applying the imidazopyridine zolpidem. To test the degree of potentiation by zolpidem, the peak current elicited by a GABA concentration that was at the EC20 derived from the respective GABA dose-response curve was considered as control, and then the drug was coapplied with GABA (Fig. 2, A and B). As shown in Fig. 2C, for GABAA receptors in beta 3 +/+ mice cortical neurons at both DIV7 and DIV15, the GABA-induced currents were slightly potentiated by zolpidem (100 nM). On the other hand, this drug induced a threefold larger potentiation of GABA response in neurons from beta 3 -/- than from beta 3 +/+ mice at both ages in culture tested (Fig. 2C).



View larger version (17K):
[in this window]
[in a new window]
 
Fig. 2. Whole cell patch-clamp recordings of GABA currents in cortical neurons from genetically altered mice (beta 3 -/-). Whole cell inward Cl- currents elicited by GABA at the EC20 in voltage-clamped cortical neurons at DIV7 are differentially potentiated by zolpidem (100 nM) in a neuron from a culture from beta 3 +/+ mice (A) and a neuron from a culture from beta 3 -/- mice (B). In C, the summary of the experiments is shown demonstrating the potentiation of GABA activated currents in these neurons at 2 distinct days in vitro (DIV) in >= 3 beta 3 +/+ and 3 beta 3 -/- mice. EC20 for GABA was similar in neurons at DIV7 and DIV15. Number of cells is indicated in parenthesis. *P < 0.005.

IPSCs in beta 3 -/- neurons

We studied mIPSCs at DIV15 in 31 cortical neurons in cultures from four beta 3 +/+ mice and 21 cortical neurons from four beta 3 -/- mice. While some neurons without mIPSCs were found in both genotypes, their occurrence was not significantly different. mIPSCs amplitude and frequency of occurrence were extremely variable between beta 3 +/+ neurons [45 ± 28 pA; 1.3 ± 0.9 (SD) Hz] and were not significantly different from beta 3 -/- neurons (40 ± 39 pA; 1.2 ± 1.3 Hz). In contrast, the weighted time constant resulting from the double-exponential fitting of the mIPSCs decay (tau w) was 2.5-fold larger in the beta 3 +/+ than in beta 3 -/- neurons (Fig. 3). The coefficient of variation of the mIPSCs decay for both genotypes was 0.45. At DIV7, mIPSCs could not be investigated because the strong depression of event frequency with TTX in these young neurons prevented reliable measurement. However, the tau w from sIPSCs (without TTX) was faster in beta 3 -/- than in beta 3 +/+ neurons (Fig. 3C).



View larger version (23K):
[in this window]
[in a new window]
 
Fig. 3. Whole cell patch-clamp recordings of synaptic currents in beta 3 -/- cortical neurons. A: the occurrence of minitaure inhibitory postsynaptic currents (mIPSCs; in TTX) is illustrated on a slow time scale in cortical neurons from DIV15 cultures of beta 3 +/+ mice (top) and beta 3 -/- mice (bottom). B: averages of 50 currents recorded from individual cortical neurons from DIV15 cultures of beta 3 +/+ mice (top) and beta 3 -/- mice (bottom) are illustrated with a superimposed double-exponential curve with an indication of the weighted decay time constant (tau w) from the exponential fitting of these currents. C: the summary data on weighted time constant from the exponential fitting of these currents are compared between mice and distinct days in vitro. Data from DIV7 mice are from sIPSCs (no TTX). Bars indicate the average values. Data derive from >= 3 distinct mice in each group with the total number of cell indicated in parenthesis over the bars. * P < 0.01.

We then compared the effects of zolpidem (100 nM) on sIPSCs and mIPSCs recorded, respectively, from neurons at DIV7 and DIV15 (Fig. 4). In cells from beta 3 -/- mice, zolpidem prolongation of both sIPSCs and mIPSCs was significantly larger compared with cells from beta 3 +/+ mice (Fig. 4). In 11 beta 3 +/+ and 8 beta 3 -/- cortical neurons in culture at DIV15, we also compared the prolongation of mIPSCs decay by the beta 2/3 selective drug loreclezole (Fisher et al. 2000; Wafford et al. 1994). Bath perfusion with 10 µM loreclezole, prolonged the tau w by 115 ± 19 versus 149 ± 32%, in neurons from the beta 3 +/+ and beta 3 -/- mice, respectively. The prolongation of mIPSCs decay was not statistically different between the two groups.



View larger version (23K):
[in this window]
[in a new window]
 
Fig. 4. Effects of the imidazopyridine zolpidem on mIPSCs in cortical neurons from genetically altered mice. mIPSCs recorded in cortical neurons in primary culture (DIV15) are illustrated before and after zolpidem perfusion in a beta 3 +/+ mouse (A) and in a homozygote beta 3 -/- mice (B). C: the percent prolongation of the decay time constants of mIPSCs (DIV15) and sIPSC (DIV7) by 100 nM zolpidem is reported for cultures from different mice and a distinct days in vitro. Data derive from 3 mice in each group. *, significant with respect to beta 3 +/+ mice (P < 0.05).

alpha subunit expression in beta 3 -/- neurons

Our electrophysiological data suggest a change in alpha  subunit composition of GABAA receptors resulting from the beta 3 subunit deletion. For instance, a larger participation of the alpha 1 subunit or a reduction of alpha 2/alpha 3 subunits could both enhance zolpidem sensitivity and decrease synaptic current duration. We therefore used surface immunolabeling with specific antibodies against the alpha 1, alpha 2, alpha 3, and alpha 5 subunits to verify the extent of expression of these subunits in cortical neurons in primary cultures from beta 3 +/+ and beta 3 -/- mice. We also used for comparison an antibody specific for the beta 2/beta 3 subunits. We followed the protocol suggested in Brunig et al. (2002) with surface staining with primary antibodies in live cells followed by fixation and secondary antibody staining to minimize antigen capping by the secondary antibodies in living cells.

A comparison of various alpha  and beta 2/3 subunits staining in cortical neurons from both genotypes was assessed from fluorescent and phase contrast microphotographs as percent of the total neurons expressing these subunits counted in at least six coverslips from DIV15 cultures deriving from three distinct mice in each group. A significant reduction of the number of cells expressing alpha 2 (from 81 ± 7 to 46 ± 7%, n = 202 neurons) as well as alpha 3 subunits (from 75 ± 5 to 32 ± 10%, n = 140) was detected, whereas no change was observed for alpha 1 subunit (from 76 ± 6 to 61 ± 9%, n = 192) in beta 3 -/- mice. As expected, deletion of the beta 3 subunit resulted in decreased staining with a beta 2/beta 3-specific antibody (from 89 ± 7 to 50 ± 7%, n = 138), indicating that the beta 2 subunit is still present and that it does not compensate for the lack of beta 3 subunit, as previously reported (Homanics et al. 1997).

In Fig. 5 examples of neurons stained live revealed clusters of GABAA receptors subunits in dendrites from cortical neurons. In most cells from beta 3 +/+ mice, punctate staining on the membrane was more prominent for the alpha 2 than for the alpha 1 and alpha 3 subunits. Staining for the alpha 5 subunit was very weak and it was not different between genotypes (not shown). In Table 1, we report the results of an assessment of density of receptor clusters (number of clusters per 10 µm) for alpha  subunit isoforms expressed on the surface of dendrites of neurons from beta 3 +/+ and beta 3 -/- mice. There was a significant reduction in cluster density for both alpha 2 and alpha 3 subunits, whereas, no significant change in density of clusters was seen when surface expression was evaluated with an antibody for beta 2/3 subunits. A striking effect of beta 3 deletion was observed when the relative fluorescence intensity of clusters was compared between neurons from beta 3 +/+ and beta 3 -/- mice. As shown in Table 1, while the average cluster intensity did not change for the alpha 1 subunit, it was significantly decreased for both alpha 2, alpha 3, and beta 2/3 subunits.



View larger version (96K):
[in this window]
[in a new window]
 
Fig. 5. Expression of distinct alpha  subunits of the GABAA receptor in beta 3 +/+ and beta 3 -/- neurons. Mouse cortical neurons were immunostained live at DIV15 with specific antibodies against alpha 1, alpha 2, and alpha 3 subunits. Cells were then fixed and stained with Cy3-conjugated secondary antibodies. Each panel shows micrograph of Cy3 fluorescence for cells derived from beta 3 +/+ (left) or beta 3 -/- (right) mice. Insets with partial segments of dendrites are shown in each panel illustrating cluster of receptor subunits. Scale bar 20 and 7 µm for insets.


                              
View this table:
[in this window]
[in a new window]
 
Table 1. GABAA receptor subunit clusters in dendrites of cortical neurons in culture from beta 3 +/+ and beta 3 -/- mice

beta 3 subunit transfection in beta 3 -/- neurons

We used a modification of calcium phosphate mediated DNA transfection to introduce cDNA for the beta 3 subunit and EGFP into cortical neurons from beta 3 -/- mice. Three coverslips of cultures from a beta 3 -/- mouse were transfected at DIV5, and electrophysiological and immunocytochemical studies were performed at DIV15. In Fig. 6, a cortical neuron expressing EGFP has been surface stained with beta 2/3 antibody. Surface expression of the subunit was similar to that seen in neurons from beta 3 +/+ mice and contrasts with the weaker staining seen in neurons from beta 3 -/- mice (Fig. 6). In 28 transfected neurons from the three coverslips, 91% of cells had beta 2/3 staining significantly higher than twice the background. In 10 beta 3 transfected neurons from two coverslips, surface staining for the alpha 2 and alpha 3 subunit revealed that all these cells were positive for both subunits. In beta 2/3 antibody-stained neurons, when average dendritic cluster intensity was compared between neurons in culture from beta 3 +/+ mice and beta 3 transfected neurons in cultures from beta 3 -/- mice, no significant differences were observed. Similar results were obtained when cluster intensity was compared for alpha 2 and alpha 3 antibody staining in neurons in culture from beta 3 +/+ mice and beta 3 transfected neurons in cultures from beta 3 -/- mice. Decay time of mIPSCs recorded in five beta 3 transfected cells (tau w, 51 ± 7 ms) were not different from those from beta 3 +/+ neurons. Zolpidem (100 nM) prolonged the tau w of mIPSC by 26 ± 5%, a similar extent to that observed in beta 3 +/+ neurons.



View larger version (80K):
[in this window]
[in a new window]
 
Fig. 6. Transfection of the beta 3 subunit in beta 3 -/- neurons. A: surface anti-beta 3-cy3 staining in (+/+) and (-/-) neurons. B: EGFP fluorescence (left) and anti-beta 3-Cy3 surface staining (right) in beta 3 -/- neurons cotransfection with beta 3 cDNA and EGFP. Scale bar 20 µm.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

We have studied GABAA receptors in cortical neurons in primary cultures from embryonic mice with and without the deletion of the beta 3 subunit. Our results show a reduced GABA current density, enhanced sensitivity to zolpidem, and shorter duration of m- and sIPSCs in neurons from beta 3 -/- mice. Current density reduction of a similar extent was observed in cultured hippocampal neurons from these mice together with the small changes we observed in GABA sensitivity (Krasowski et al. 1998). We complement these results by showing that the enhancement of whole cell current with the alpha 1-subunit-selective drug zolpidem is considerably larger in neurons from beta 3 -/- mice than in beta 3 +/+ mice. Smaller and faster sIPSCs were previously reported both in neurons of the reticular thalamic nucleus (Huntsman et al. 1999) and in granule neurons in the olfactory bulb (Nusser et al. 2001) in slices from beta 3 -/- mice. We have observed shortening of sIPSCs and mIPSCs as result of the beta 3 subunit deletion in cortical neurons. However, the heterogeneity between neurons and the large variability in size of mIPSCs has prevented rigorous assessment of differences in mIPSCs amplitude between beta 3 +/+ and beta 3 -/- neurons.

We studied the prolongation of mIPSC duration by zolpidem and loreclezole, drugs selective for the alpha 1 and beta 2/3 subunits, respectively (Pritchett et al. 1989; Wafford et al. 1994). Zolpidem action was considerably enhanced in neurons from beta 3 -/- mice relative to beta 3 +/+, whereas the effect of loreclezole was unchanged. These results suggest that the beta 3 subunit deletion has produced a selective retention of alpha 1 subunit containing GABAA receptors. They also suggest that no other beta  subunit is able to substitute for the beta 3 subunit and that the remaining functional GABAA receptors are beta 2 rather than beta 1 containing as previously suggested (Homanics et al. 1997). Quantification of surface immunocytochemical staining with subunit selective antibodies revealed that both the number of positive neurons and dendritic subunit cluster density and fluorescent intensity for the alpha 2 and alpha 3 subunits were significantly reduced in cultures from beta 3 -/- mice. A similar reduction was not observed for the alpha 1 subunit. Furthermore, the fluorescent intensity of dendritic GABA receptor clusters stained with beta 2/3 antibody, was significantly lower in beta 3 -/- neurons. Taken together our results suggest that beta 2 and beta 3 subunit form separate pools of receptors with specific alpha  subunit. The immunocytochemical results support the electrophysiological finding of a selective retention of alpha 1 subunit containing GABAA receptor in beta 3 -/- mice and imply that these receptors are co-assembled with the beta 2 subunit whereas the majority of alpha 2 and/or alpha 3 subunits are assembled with the beta 3 subunit.

The density of dendritic GABAA receptor clusters stained with beta 2/3 antibody, was not decreased in neurons from beta 3 -/- mice compared with beta 3 +/+ mice. This may suggest that the deletion of the beta 3 subunit in mice does not affect the formation of clusters unlike what is observed with the gamma 2 subunit deletion (Essrich et al. 1998). The reduction in cluster density of alpha 2 and alpha 3 subunits may relate to the decreased surface expression of those subunits rather than to the inability of those subunits to form clusters. This supports the pivotal role for beta  subunit in surface expression and localization of GABAA receptor subtypes (Connolly et al. 1996; Connor et al. 1998). Our data suggest specificity for the beta 3 subunit in allowing surface expression of alpha 2 and alpha 3 subunit receptor subtypes. This suggestion is further supported by the results that show that beta 3 cDNA transfection in neurons from beta 3 -/- mice restored beta 2/3, alpha 2, and alpha 3 subunit surface staining, slowed mIPSC decay and decreased zolpidem prolongation.

The similar cluster density between alpha 1, alpha 2, and beta 2/3 subunits stain in beta 3 +/+ neurons and the lack of reduction of cluster density with beta 2/3 subunit stain in beta 3 -/- neurons indicates that receptors pools containing these subunits coexist in the same puncta in beta 3 +/+ neurons. This suggestion is supported by the similar coefficient of variation measured for mIPSCs decays in neurons from beta 3 +/+ and beta 3 -/- mice. In fact, if synapses were made on a separate population of alpha 1 and alpha 2/alpha 3 subunit containing receptor clusters in beta 3 +/+ mice, one would expect a larger variation of decay than in beta 3 -/-.

Native and recombinant GABAA receptors containing the alpha 1 subunit have a faster time course than those with alpha 2 or alpha 3 subunits. (Gingrich et al. 1995; Lavoie et al. 1997; McClellan and Twyman 1999; Verdoon 1994). This result suggests that deletion of the beta 3 subunit left alpha 1 containing GABAA receptor isoforms endowed with faster decay kinetics. Alternatively, the acceleration in the deactivation kinetics could be explained by the presence of beta 2 rather than beta 2/beta 3 receptors. Our finding of increased zolpidem sensitivity of sIPSCs duration in the beta 3 -/- mice cortical neurons favors the alpha 1 subunit as being responsible for short mIPSCs in cortical neurons from these mice. Further work that will characterize the deactivation properties of recombinant receptors with distinct beta  subunit isoforms will ultimately address this issue.

The suggestion that alpha l-containing receptors are selectively retained in beta 3 -/- neurons, implies that they are likely co-assembled with the beta 2 subunit. This lend further support to the hypothesis that two major types of GABAA receptor can be found throughout the CNS, one with slow kinetics composed of alpha 2/alpha 3 subunits together with the beta 3 subunit and another with fast kinetics where alpha 1 together with beta 2 are the major players. Support for this hypothesis comes from anatomical and biochemical data that show the preferential association of the alpha 2 with the beta 3 subunit and the alpha 1 with the beta 2 subunit (Benke et al. 1994; Fritschy et al. 1994). Because benzodiazepines affecting alpha 1 subunits are sedative and those affecting alpha 2 are anxiolytic (Mohler et al. 2002), it is possible that slow decaying IPSCs allow inhibitory neurons to produce stronger and longer-lasting inhibition perhaps associated with a decrease in vigilance and in generalized anxiety while those associated with fast IPSCs are target for sedation. Fast IPSCs in beta 3 -/- mice may underlie the generalized seizures reported in behavioral studies of these mice (DeLorey et al. 1998; Homanics et al. 1997). Additionally, given the pivotal role of GABA in early development (Maric et al. 2001) and the high expression of alpha 2- and alpha 3-containing receptors at early stages in life (Hornung and Fritschy 1996; Laurie et al. 1992; Poulter et al. 1992), the reduction of expression of receptors containing these subunits may possibly be related to the severe developmental malformation and behavioral impairment observed in these mice.


    ACKNOWLEDGMENTS

The authors acknowledge the expert technical support of J. Steinmiller and C. Ferguson and thanks to J. Marc Fritschy for helpful discussion.

This work was supported by National Institutes of Health Grants DA-02997, and NS-38080 to J. H. Neale; MH-01680 and MH-64797 to S. Vicini; and AA-10422, GM-47818, and GM-52035 to G. E. Homanics.


    FOOTNOTES

Address for reprint requests: S. Vicini, Dept. of Physiology and Biophysics, Georgetown University, Box 571460, Basic Science Bldg. Rm. 225, Washington, DC (E-mail: svicin01{at}georgetown.edu).


    REFERENCES
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES


0022-3077/03 $5.00 Copyright © 2003 The American Physiological Society



This article has been cited by other articles:


Home page
J. Physiol.Home page
M. B. Herd, A. R. Haythornthwaite, T. W. Rosahl, K. A. Wafford, G. E. Homanics, J. J. Lambert, and D. Belelli
The expression of GABAA {beta} subunit isoforms in synaptic and extrasynaptic receptor populations of mouse dentate gyrus granule cells
J. Physiol., February 15, 2008; 586(4): 989 - 1004.
[Abstract] [Full Text] [PDF]


Home page